Who is sponsoring NCT01644435?

NCT01644435 is sponsored by Kasiak Research Pvt. Ltd..

What condition does NCT01644435 study?

NCT01644435 studies ACNE SCARRING.

What drugs are being tested in NCT01644435?

Interventions: Autologous Human Platelet Lysate, Autologous Human Platelet Lysate.

What is the status of NCT01644435?

NCT01644435 is currently COMPLETED.

Last reviewed 2012-10-12 · How we verify

A Prospective, Multicentric, Open Label, Bio Interventional, Phase I, Phase II Pilot Study to Evaluate the Safety and Efficacy of Autologous Human Platelet Lysate (HPL) for Treatment of Acne Scarring

NCT01644435 Phase 1/Phase 2 COMPLETED

This is a multicentre, open label, randomized, pilot study to evaluate safety and efficacy of Human Platelet Lysate (HPL) in subjects with Acne Scarring. The study is being conducted at 2 centers in India. The primary endpoint is change in the Global Acne scarring classification scores from screening to end of the study. The secondary endpoints are Photographic Assessment, Physicians assessment score and Patients self assessment score.

Details

Lead sponsor	Kasiak Research Pvt. Ltd.
Phase	Phase 1/Phase 2
Status	COMPLETED
Enrolment	19
Start date	2012-05
Completion	2012-10

Conditions

ACNE SCARRING

Interventions

Autologous Human Platelet Lysate
Autologous Human Platelet Lysate

Primary outcomes

Changes in the Global Acne scarring classification — Day 0, End of study - Month 3

Countries

India